Anisodamine ointment for treating frostbite and sclerema neonatorum and method for preparing same
A technology for anisodamine and scleredema, applied in the field of pharmaceutical preparations, can solve the problems of ineffective curative effect, inability to cure in time, long treatment time, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0017] December 2004-January 2005, follow-up of chilblain outpatients: main manifestations: redness and swelling in different degrees on ears, face, back of hands and toes, dark red skin. At the same time, there is pain, pain, and itching in these chilblains.
[0018] Among them are two patients, one is a 35-year-old man who is a vegetable farmer; the other is a 38-year-old woman who sells vegetables in the market. Both patients had different degrees of ulceration on the back of their hands and came to the clinic. After cleaning, apply anisodamine ointment, and do venous blood and liver function tests. The following table:
[0019] Total protein
[0020] Healed after 6 days with ointment. In this outpatient case, there was no change in the routine tests of venous blood and liver function before and after medication.
Embodiment 2
[0022] At the end of the investigation, peripheral blood was measured on 8 people, and 6 of them were comprehensively counted. Before medication, white blood cells 5×10 3 ~6×10 3 u / L, hemoglobin concentration 10.5-13.2g, lymphocyte percentage 38-40%, monocyte percentage 3-4%, neutrophil percentage 50-65%; after medication, there is no obvious change in re-examination, generally fluctuating at 0 Between ~3.
Embodiment 3
[0024] 147 patients with scleredema of newborns, including 72 females and 75 males, all had peripheral blood examinations. The average white blood cells ranged from 15×10 to 20×10u / L, and 2 cases ranged from 21×10u / L. The hemoglobin concentration The fluctuation was 180-195g / L, and the rest remained unchanged. In the observation of pediatric inpatient treatment, sclerosis can be cured within 2 to 5 days after medication, and the effect is obvious.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com